Vice President, Project Management Early/Late Drug Development

Working with Us
Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us.

Position Title: Vice President, Project Management Early/Late Drug Development

Position Summary:

The Vice President of Project Management serves as an industry thought leader and to coach and develop a high performing project management organization across early and late drug development ranging from research through commercial launch and lifecycle management in close partnership with Global Program Leadership. This role is pivotal in ensuring the successful progression of drug candidates from early-stage research through late-stage clinical development and regulatory approval. The Vice President will work closely with cross-functional leadership to drive project success and align with the company's strategic goals.

Key Responsibilities:

• Leadership & Strategy: Provide Strategic direction and leadership for the project management organization, ensuring alignment to the company’s objectives. Build industry leading asset project management capability across DD to drive pipeline execution influencing asset and portfolio level decisions through identification of interdependencies and downstream implications across research, clinical, regulatory, medical and commercialization. Influence decision making in context of building value for portfolio versus progression of individual assets.

• Team Management: Lead, mentor, and develop a high performing project management organization, across early and late drug development as a centralized capability, to drive portfolio excellence through standardized operating best practices across drug development therapeutic areas, fostering a culture of excellence and continuous improvement. Continually builds project management capabilities and serve as the process owner of asset progression across governance checkpoints from FIH to Registration & Submission. Mentors and guides development of talent, which includes succession and development planning, performance management, and recognition of the P&SO project management team. Enable cross-TA talent development opportunities to build a talent pipeline across the BMS portfolio. 

• Portfolio Operations & Risk Management: leads global program team objective management, integrated portfolio operations, portfolio health and risk management and portfolio prioritization in partnership with Therapeutic Area Leadership, Commercial, Business Insights and Technology, Portfolio Strategy Implementation & Reporting​.  Maintain oversight of portfolio and proactively identify and escalate systemic issues which require TA, portfolio, or enterprise-level action.

• Project Oversight: Oversee the planning, execution, and delivery of early and late drug development programs, ensuring they are completed on time, within scope, and within budget.

• Stakeholder Engagement: Collaborate with internal and external stakeholders, including executive leadership in Research, Development, regulatory, safety, biometrics and data sciences, development operations, clinical, product development, commercial, medical and enabling business partners to ensure project alignment and success. For projects that are being jointly developed, ensures project managers are working closely with a key strategic alliance partner.

• Cross-Functional Collaboration & Communication: Effective communication and collaboration among diverse teams, such as R&D, clinical, regulatory, and commercial teams, are facilitated by the VP. This ensures that all departments are aligned with project goals and timelines, reducing the chances of miscommunication and delays

• Establishes and leads forums and community of practices to drive best practices across the proj